For decades, Parkinson’s disease has been framed as a simple story of dwindling dopamine, a slow erosion of the brain’s ...
A 67-year-old says a new £2,000 device, which is being studied by the NHS, has improved his sleep and allowed him to go back ...
In patients with advanced Parkinson's disease (PD), quality of life (QoL) remains stable at 5 years in those who receive deep brain stimulation of the subthalamic nucleus (STN-DBS) vs standard-of-care ...
A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how ...
Parkinson’s disease is a progressive disorder of later life, defined clinically by motor features (asymmetric bradykinesia, rigidity, tremor, and imbalance) and pathologically by neuronal degeneration ...
As anyone who has ever heard “their song” can attest, the right music has the power to make you move. Now, healthcare providers are trying to harness this power to help patients with a disabling ...
A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how ...
Jan. 14 -- WEDNESDAY, Jan. 13 (HealthDay News) -- Reduced dosages of dopamine agonists, drugs routinely used to treat Parkinson's disease, can cause symptoms similar to those experienced by addicts in ...
Parkinson’s Disease is a progressive neurodegenerative disorder in which the brain’s ability to produce dopamine, an essential neurotransmitter, is damaged, leading to symptoms including tremors, ...